TW201129358A - Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation - Google Patents

Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation

Info

Publication number
TW201129358A
TW201129358A TW100105404A TW100105404A TW201129358A TW 201129358 A TW201129358 A TW 201129358A TW 100105404 A TW100105404 A TW 100105404A TW 100105404 A TW100105404 A TW 100105404A TW 201129358 A TW201129358 A TW 201129358A
Authority
TW
Taiwan
Prior art keywords
inhibition
food
medicines
antiobesity agent
lipid accumulation
Prior art date
Application number
TW100105404A
Other languages
Chinese (zh)
Other versions
TWI417091B (en
Inventor
Tomihisa Ohta
Fumihide Takano
Takanori Tatsuno
Tomoya Takahashi
Takayuki Shimizu
Original Assignee
Arsoa Honsha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arsoa Honsha Corp filed Critical Arsoa Honsha Corp
Publication of TW201129358A publication Critical patent/TW201129358A/en
Application granted granted Critical
Publication of TWI417091B publication Critical patent/TWI417091B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

An objective of the present invention is to provide an antiobesity agent free of side effects, safe in use, and with excellent function in inhibition of lipid accumulation, and medicines, food or cosmetics free of side effects, safe in use, and with excellent function in inhibition of lipid accumulation. To achieve the objective, the present invention provides an antiobesity agent containing rhinacanthin D represented by the formula (1), and an antiobesity agent containing a novel compound A represented by the following formula (2). The present invention also provides medicines, food or cosmetics containing the antiobesity agents.
TW100105404A 2010-02-19 2011-02-18 Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect TWI417091B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010034947 2010-02-19

Publications (2)

Publication Number Publication Date
TW201129358A true TW201129358A (en) 2011-09-01
TWI417091B TWI417091B (en) 2013-12-01

Family

ID=44462488

Family Applications (2)

Application Number Title Priority Date Filing Date
TW102130967A TWI453016B (en) 2010-02-19 2011-02-18 Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect
TW100105404A TWI417091B (en) 2010-02-19 2011-02-18 Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW102130967A TWI453016B (en) 2010-02-19 2011-02-18 Anti-obesity agents and pharmaceuticals, foods or cosmetics that have a fat accumulation inhibitory effect

Country Status (3)

Country Link
JP (1) JP5602049B2 (en)
CN (2) CN103030620B (en)
TW (2) TWI453016B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012169654A1 (en) * 2011-06-07 2012-12-13 学校法人慶應義塾 Carbon-monoxide(co)-assisted inhibition of fatty acid and cholesterol uptake
CN107708717B (en) * 2015-07-04 2021-05-14 株式会社奥碧慧央集团 Application of rhinacanthin quinone C as nerve cell apoptosis inhibitor
KR101784261B1 (en) 2016-05-17 2017-10-11 주식회사 스템모어 Composition containing prenylated naphthoquinone or pharmaceutically acceptable salts thereof as an active ingredient for anti-virus
CN108003211A (en) * 2017-12-22 2018-05-08 福建农大菌草技术开发公司 A kind of method of quick separating ganoderic acid in accessory substance from ganoderma lucidum
CN111658527B (en) * 2020-06-30 2022-10-21 重庆市康万佳中药饮片有限公司 Pig zero-drug making method and device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3397552B2 (en) * 1995-11-27 2003-04-14 株式会社アルソア本社 Cosmetics
JP3077019B2 (en) * 1995-12-20 2000-08-14 株式会社アルソア本社 Excretion enhancer
JP3317901B2 (en) * 1998-06-26 2002-08-26 株式会社アルソア本社 Lipid peroxide inhibitor for epilepsy and method for producing the same
JP2002053481A (en) * 2000-08-10 2002-02-19 Arsoa Honsya Corp Anti-malignant tumor agent
JP2003089630A (en) * 2001-09-19 2003-03-28 Arsoa Honsya Corp Bleaching agent
US7618662B2 (en) * 2004-12-22 2009-11-17 Avon Products, Inc Use of natural plant extracts in cosmetic compositions
CN1311752C (en) * 2005-02-21 2007-04-25 鲁汝协 Healthy tea and its preparing method
CN1331502C (en) * 2005-10-24 2007-08-15 袁莉 Chinese medicine composition
CN103467293B (en) * 2010-02-19 2015-06-10 株式会社安露莎 Novel compound and application thereof in pharmaceuticals, food or cosmetics with anti-tumor function

Also Published As

Publication number Publication date
CN102160862A (en) 2011-08-24
JP2011190251A (en) 2011-09-29
TWI453016B (en) 2014-09-21
CN102160862B (en) 2013-06-26
TW201350115A (en) 2013-12-16
JP5602049B2 (en) 2014-10-08
CN103030620B (en) 2014-10-22
TWI417091B (en) 2013-12-01
CN103030620A (en) 2013-04-10

Similar Documents

Publication Publication Date Title
NZ626618A (en) Hydroxamic acid derivatives and uses thereof
IN2014MN02288A (en)
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
MY184978A (en) Pyridin-2-amides useful as cb2 agonists
MX2012007098A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
MX353086B (en) A capsule for use in a food preparation machine.
MX2012007161A (en) Phenol derivatives and pharmaceutical or cosmetic use thereof.
NZ603151A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives
BR112012028717A2 (en) personal care formulations containing alkyl ketal esters and manufacturing methods
MY162146A (en) Pharmaceutical composition
TNSN08381A1 (en) Cosmetic active ingredient composed of arginine ferrulate and a microalgae and extract its uses
UA114656C2 (en) Novel pyridine derivatives
MX367561B (en) Cosmetic composition.
WO2012027073A8 (en) Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes
MX342947B (en) Treatment of type 2 diabetes.
TW201129358A (en) Antiobesity agent and medicines, food or cosmetic with function in inhibition of lipid accumulation
IN2015DN03998A (en)
EP2588096A4 (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
IN2014DN09256A (en)
PH12015502429A1 (en) Dicarboxylic acid compound
IN2014DN10449A (en)
MX2015015755A (en) Perhydroquinoxaline derivatives useful as analgesics.
EA201590708A1 (en) MODIFIED HYALURONIC ACID DERIVATIVES AND THEIR APPLICATION
BR112015026265A2 (en) personal care compositions containing zinc pyrithione and a metal phosphonate complex
TW201129394A (en) Composition for inhibiting melanogenesis and use thereof